Traditional Chinese medicine in antiviral treatment

TMR Integrative Medicine

article

Hua Wang¹  Qin Wang¹  Jia-Yu Chen¹  Guo-Juan Shi¹  Lin-Wei Chen¹ 

[1] Taizhou Hospital Affiliated to Nanjing University of Chinese Medicine

关键词: Traditional Chinese medicine;    Antiviral treatment;    Mechanism;    Research status;    Prospect;   

DOI  :  10.12032/TMRIM202004014

学科分类：医学（综合）

来源: TMR publishing group

【 摘 要 】

The Novel Coronavirus (COVID-19), which broke out in Wuhan, China in December 2019, attracted worldwideattention. With a long incubation period and strong infectiousness, COVID-19 poses a great threat to the life andhealth worldwide with high incidence, high pathogenicity and low sensitivity to antibiotics. At present, there areless kinds of antiviral drugs, including rimantadine hydiochloride, acyclovir, interferon, zidovudine, ribavirin, etc., which maybe lead to severe adverse reactions of the nervous system, hematopoietic system, liver and kidneysystem, as well as side effects such as nausea, vomiting, upper abdominal discomfort and diarrhea. Meanwhile, thedevelopment of antiviral drugs requires huge investment and time, the development of effective antiviral drugs andvaccine lags far behind the rapidly developed disease. Traditional Chinese medicine has played an important roleagainst the infection, especially in the fight against severe acute respiratory syndrome, H1N1 influenza, H7N9 fluvirus, middle east respiratory syndrome and Ebola virus infection. In this paper, the classification, mechanism, existing problems and the prospect of traditional Chinese medicine in antiviral treatment has been summarized inorder to provide certain reference for the research and prescription screening of traditional Chinese medicineanti-COVID-19 drugs.

【 授权许可】

CC BY